Skip to main content
Livermore
Livermore
ZHEN

ESSA Pharma Inc.

EPIXDelisted Oct 9, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001633932

ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.

Holders of 5% or more of EPIX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of ESSA Pharma Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of EPIX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Soleus Capital Master Fund, L.P.13D/A9.80%4.36M shares+4.70 ppfrom 5.10%Apr 15, 20253 filingsJul 21, 2025SEC
BML Investment Partners, L.P.13D9.50%4.22M shares0.00 ppfrom 9.50%Feb 14, 20253 filingsApr 24, 2025SEC
Soleus Capital, LLC13G/A5.10%2.26M shares–Feb 12, 20215 filingsFeb 11, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

51 Schedule 13D and 13G filings on ESSA Pharma Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on EPIX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 14, 20254:17 PM ETTang Capital Management LLCand 6 others13G/A0.00%0 shares0.00 ppfrom 0.00%Below 5%Sep 30, 2025SEC
Nov 14, 20254:15 PM ETTang Capital Management LLCand 6 others13G/A0.00%0 shares−9.70 ppfrom 9.70%Below 5%Sep 30, 2025SEC
Oct 14, 20255:30 PM ETBiotechnology Value Fund L Pand 9 others13D/A0.00%0 shares−24.70 ppfrom 24.70%Below 5%Oct 9, 2025SEC
Oct 7, 20254:12 PM ETMorgan Stanleyand 1 other13G/A4.00%1.90M shares–Below 5%Sep 30, 2025SEC
Aug 7, 20254:31 PM ETBiotechnology Value Fund L Pand 9 others13D/A24.70%11.7M shares+5.00 ppfrom 19.70%Aug 5, 2025SEC
Jul 30, 20254:15 PM ETTang Capital Management LLCand 6 others13G9.70%4.30M sharesNewJul 30, 2025SEC
Jul 21, 20254:30 PM ETSoleus Capital Master Fund, L.P.and 5 others13D/A9.80%4.36M shares+4.70 ppfrom 5.10%Jul 17, 2025SEC
Apr 24, 20258:56 AM ETBML Investment Partners, L.P.13D9.50%4.22M shares0.00 ppfrom 9.50%Apr 24, 2025SEC
Apr 23, 20259:45 PM ETSoleus Capital Master Fund, L.P.and 5 others13D/A5.10%2.26M shares0.00 ppfrom 5.10%Apr 23, 2025SEC
Apr 15, 20254:46 PM ETSoleus Capital Master Fund, L.P.and 5 others13D5.10%2.26M sharesNewApr 15, 2025SEC
Apr 9, 20259:00 AM ETBiotechnology Value Fund L Pand 9 others13D19.70%8.75M shares–Apr 9, 2025SEC
Feb 14, 20254:06 PM ETPFM Health Sciences, LPand 3 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Feb 14, 202510:26 AM ETBML Investment Partners, L.P.13G/A9.50%4.22M shares+0.10 ppfrom 9.40%Dec 31, 2024SEC
Feb 14, 20259:49 AM ETBML Investment Partners, L.P.13G/A9.40%4.18M shares–Dec 31, 2024SEC
Feb 14, 20259:00 AM ETRTW Investments, LPand 1 other13G/A2.50%1.11M shares–Below 5%Dec 31, 2024SEC
Feb 11, 20254:00 PM ETSoleus Capital, LLCand 6 others13G/A5.10%2.26M shares–Dec 31, 2024SEC
Feb 14, 2024PFM Health Sciences, LP13G/AOld format–––SEC
Feb 14, 2024RTW Investments, LP13GOld format–––SEC
Feb 13, 2024BB Biotech AG13G/AOld format–––SEC
Feb 8, 2024Morgan Stanley13GOld format–New–SEC
Jan 23, 2024Soleus Capital, LLC13G/AOld format–––SEC
Feb 14, 2023Eventide Asset Management, LLC13G/AOld format–––SEC
Feb 14, 2023BB Biotech AG13G/AOld format–––SEC
Feb 14, 2023PFM Health Sciences, LP13G/AOld format–––SEC
Feb 14, 2023Soleus Capital, LLC13G/AOld format–––SEC
Feb 14, 2023Avidity Partners Management LP13G/AOld format–––SEC
Feb 14, 2023RTW Investments, LP13G/AOld format–––SEC
Feb 9, 2023Janus Henderson Group PLC13G/AOld format–––SEC
Nov 10, 2022PFM Health Sciences, LP13GOld format–New–SEC
Oct 27, 2022Avidity Partners Management LP13GOld format–New–SEC
Jul 12, 2022Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 14, 2022Eventide Asset Management, LLC13G/AOld format–––SEC
Feb 14, 2022Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 14, 2022RTW Investments, LP13G/AOld format–––SEC
Feb 11, 2022Janus Henderson Group PLC13GOld format–New–SEC
Feb 11, 2022Vivo Capital IX, LLC13G/AOld format–––SEC
Feb 11, 2022BB Biotech AG13G/AOld format–––SEC
Feb 11, 2022Pfizer Inc13G/AOld format–––SEC
Feb 10, 2022Soleus Capital, LLC13G/AOld format–––SEC
Jan 12, 2022Clarus Lifesciences III, L.P.13D/AOld format–––SEC
Aug 23, 2021Driehaus Capital Management LLC13G/AOld format–––SEC
Aug 17, 2021BB Biotech AG13G/AOld format–––SEC
Jul 2, 2021RTW Investments, LP13GOld format–New–SEC
May 5, 2021BB Biotech AG13GOld format–New–SEC
Feb 16, 2021Driehaus Capital Management LLC13GOld format–––SEC
Feb 16, 2021Driehaus Capital Management LLC13GOld format–New–SEC
Feb 12, 2021Eventide Asset Management, LLC13G/AOld format–––SEC
Feb 12, 2021Vivo Capital IX, LLC13G/AOld format–––SEC
Feb 12, 2021Omega Fund IV, L.P.13G/AOld format–––SEC
Feb 12, 2021Soleus Capital, LLC13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell ESSA Pharma Inc. shares.

No Form 144 notices for ESSA Pharma Inc. are on file.